Breaking News
Friday War Room LIVE: Breaking! Multiple Democrat Judges Arrested
Are Vaccines killing our pets: VACCINES AND PET CANCER? DR. JUDY JASEK RAISES THE ALARM
The Lawfare Case You Weren't Supposed to Notice Just Got Darker:
'Financial and Ethical Misconduct' Allegations Against Davos Founder Klaus Schwab Made Publi
Top Tech News
Cramming More Components Onto Integrated Circuits
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
The Immense Complexity of a Brain is Mapped in 3D for the First Time:
SpaceX, Palantir and Anduril Partnership Competing for the US Golden Dome Missile Defense Contracts
US government announces it has achieved ability to 'manipulate space and time' with new tech
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
Cancer Remission Achieved with Low-Cost Drug | Media Blackout
3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.